Loading grant details…
Active
PROJECTS
Swiss National Science Foundation
DISCOVERY AND PRE-CLINICADEVELOPMENT OF INHALABLE RSV PEPTIDES ANTIVIRALS
$96.7M
CHF
| Funder | Swiss National Science Foundation |
|---|---|
| Recipient Organization | University of Applied Sciences and Arts Western Switzerland – Hes-So |
| Country | Switzerland |
| Start Date | Apr 01, 2025 |
| End Date | Mar 31, 2029 |
| Duration | 1,460 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swiss National Science Foundation |
| Grant ID | 32HW-0_228624 |
Grant Description
RSV
All Grantees
University of Applied Sciences and Arts Western Switzerland – Hes-So
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2025
End Year
2029
Grantees
1
Related Grants
Swiss Direct Democracy in the 21st Century (SDD-21)
Swiss National Science Foundation
$230.45M CHF
Measurement of Higgs Boson Properties with CMS and Search fo...
Swiss National Science Foundation
$182.54M CHF
Annemarie Schwarzenbach: A Digitale Edition of the Small For...
Swiss National Science Foundation
$174.74M CHF
Advertisement
